This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aventis Pharma S.a.. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: Jacques Winter: Innovator in Genetic Engineering
Introduction
Jacques Winter is a notable inventor based in Quincy-Voisins, France. He has made significant contributions to the field of genetic engineering, particularly in the development of yeast strains for steroid production. With a total of 2 patents, Winter's work has the potential to impact various industries, including pharmaceuticals and biotechnology.
Latest Patents
Winter's latest patents focus on genetically modified yeast strains that autonomously produce steroids from simple carbon sources. The first patent describes the yeast strains and their ability to generate steroids efficiently. The second patent reiterates the same innovative approach, emphasizing the method for producing steroids from these genetically modified yeast strains. This groundbreaking work showcases Winter's commitment to advancing biotechnological solutions.
Career Highlights
Jacques Winter is currently associated with Aventis Pharma S.A., where he continues to explore innovative solutions in the pharmaceutical sector. His expertise in genetic engineering has positioned him as a key player in the development of new biotechnological applications.
Collaborations
Winter has collaborated with notable colleagues, including Gilles Cauet and Tilman Achstetter. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jacques Winter's contributions to genetic engineering and his innovative patents in yeast strains for steroid production highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also opens new avenues for industrial applications.